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Vibrio, a diverse genus of aquatic bacteria, currently includes 72 species, 12 of which occur in human clinical
samples. Of these 12, three species—Vibrio cholerae, Vibrio parahaemolyticus, and Vibrio vulnificus—account for
the majority of Vibrio infections in humans. Rapid and accurate identification of Vibrio species has been
problematic because phenotypic characteristics are variable within species and biochemical identification
requires 2 or more days to complete. To facilitate the identification of human-pathogenic species, we developed
a multiplex PCR that uses species-specific primers to amplify gene regions in four species (V. cholerae, V.
parahaemolyticus, V. vulnificus, and V. mimicus). The assay was tested on a sample of 309 Vibrio isolates
representing 26 named species (including 12 human pathogens) that had been characterized by biochemical
methods. A total of 190 isolates that had been identified as one of the four target species all yielded results
consistent with the previous classification. The assay identified an additional four V. parahaemolyticus isolates
among the other 119 isolates. Sequence analysis based on rpoB was used to validate the multiplex results for
these four isolates, and all clustered with other V. parahaemolyticus sequences. The rpoB sequences for 12 of 15
previously unidentified isolates clustered with other Vibrio species in a phylogenetic analysis, and three isolates
appeared to represent unnamed Vibrio species. The PCR assay provides a simple, rapid, and reliable tool for
identification of the major Vibrio pathogens in clinical samples, and rpoB sequencing provides an additional
identification tool for other species in the genus Vibrio.
The genus Vibrio is a highly diverse group of gram-negative
bacteria that contains approximately 72 species (www.bacterio
.net). The group includes symbionts and commensals that are
found in or on marine animals, as well as many species that are
pathogenic to animals (21). There are 12 species that are rou-
tinely isolated from human clinical samples, and the diseases in
which they are implicated include diarrheal disease, septice-
mia, and wound infections (6).
Three species account for the majority of human Vibrio
infections. Toxigenic Vibrio cholerae is the causative agent of
the disease cholera and is acquired through ingestion of con-
taminated food or water. Infection may lead to a profuse,
watery diarrhea that can lead to severe dehydration and death
if left untreated. Worldwide, large outbreaks are caused by
toxigenic strains of serogroups O1 and O139 that produce the
cholera toxin, but in the United States, nontoxigenic strains
predominate among the cases reported to the Centers for
Disease Control and Prevention (CDC) (4). A total of 48 cases
of cholera occurred in the United States in 2004 and were
reported to the CDC (4), including eight cases infected with
toxigenic V. cholerae, four of which were associated with travel,
and 40 cases infected with nontoxigenic cholera. Vibrio chol-
erae accounted for 9.8% of all Vibrio isolates reported in the
United States to the CDC in 2004 (4).
Vibrio parahaemolyticus is a halophilic bacterium that natu-
rally inhabits coastal waters. Infection can result in acute gas-
troenteritis (6), and wound infections can occur as a result of
exposing an open sore to warm seawater. Infection is rarely
fatal, and the majority of cases arise from ingestion of under-
cooked seafood, especially raw oysters. A total of 240 cases
(49.3% of Vibrio cases in the United States) were reported to
the CDC in 2004 (4). Vibrio vulnificus is another pathogenic
species that is naturally present in warm seawater. The typical
route of infection is ingestion of raw oysters, but infection can
occur through wounds that are exposed to seawater or infected
organisms. The bacterium can cause wound infections, gastro-
enteritis, or septicemia (6). The species is an opportunistic
pathogen that causes severe infections in individuals who are
immunocompromised and in those with chronic liver disease;
in about 50% of such cases fatal complications result from
infection. A total of 92 isolates (18.9% of Vibrio isolates in the
United States) were reported to the CDC in 2004 (4), of which
33% caused fatal infections. Although V. parahaemolyticus ac-
counted for the majority of Vibrio infections in the United
States, V. vulnificus was responsible for 82% of the fatalities in
which a Vibrio species was implicated. Other Vibrio species that
are routinely isolated from human clinical samples include V.
alginolyticus, V. fluvialis, V. mimicus, Vibrio (Grimontia) hol-
lisae, Vibrio (Photobacterium) damsela, V. furnissii, V. cincin-
natiensis, V. harveyi, and V. metschnikovii. Of these species, V.
mimicus was of special interest to us: it is closely related to V.
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cholerae, and so it can be difficult to differentiate the two
species because they share many phenotypic characteristics (5).
V. mimicus can also carry the cholera toxin gene as well as
other virulence-associated genes that are used to identify V.
cholerae (3).
Accurate phenotypic identification of Vibrio species is prob-
lematic, largely because of the great variability in biochemical
characteristics (21). O’Hara et al. (16) evaluated six commer-
cial systems for the ability to identify the 12 species of Vibrio
found in clinical samples. They found that many isolates are
not accurately identified by commercial methods, with the ac-
curacy of systems ranging from 63.9% to 80.9% (16). Most
members of the genus are halophilic, and the addition of NaCl
is often required for enzymatic activity; however, the concen-
tration of NaCl can affect the biochemical profile and lead to
erroneous identification with at least one system (API 20E
[13]). The characteristics shared by Aeromonas and Vibrio also
result in classification of isolates in the wrong genus (1, 18).
Additional drawbacks of biochemical methods are that they
are time-extensive (i.e., reactions must incubate for an ex-
tended time period, often requiring 2 to 7 days to complete)
and that the interpretation of results requires specialized train-
ing that may not be available to all laboratories.
Molecular methods that utilize the PCR and nucleotide se-
quence determination overcome many of the limitations of
phenotypic methods. Molecular techniques, particularly nucle-
otide sequence determination, provide data that are objec-
tively scored to provide an unambiguous identification. Nucle-
otide sequences can be placed into a phylogenetic framework,
which allows an assessment of the genetic relationships among
isolates and can reveal isolates that represent undescribed spe-
cies. Most importantly, methods that utilize the PCR can lead
to identification of an isolate within hours as opposed to days
and can be used on small quantities of cells, including those
that are not viable or are otherwise unculturable.
A rapid and accurate molecular method that identifies mul-
tiple species in one assay would be a useful tool for clinical
laboratories and would enhance Vibrio surveillance and diag-
nosis. A simple molecular tool could also lead to better esti-
mates of the incidence of Vibrio infections in the United States.
While a total of 487 Vibrio isolates were reported to the CDC
in 2004 (4), the incidence of Vibrio infections is likely to be
much greater, particularly because only infections due to toxi-
genic V. cholerae serogroup O1 or O139 were nationally noti-
fiable prior to 2006.
In this report, we present a two-step approach to identify
Vibrio isolates that are pathogenic to humans: a multiplex PCR
assay to identify the most commonly encountered Vibrio iso-
lates (V. cholerae, V. parahaemolyticus, V. vulnificus, and V.
mimicus) and a robust sequence-based approach using rpoB
sequencing and phylogenetic analysis that can cluster isolates
into other Vibrio species and can clearly differentiate Vibrio
from other closely related genera, such as Aeromonas. The
multiplex PCR primarily targets variation in conserved house-
keeping genes. We also generated a Vibrio rpoB reference
database and then determined nucleotide sequence for an
870-bp portion of the rpoB gene to identify Vibrio isolates that
could not be classified on the basis of phenotype or the mul-
tiplex PCR. Sequence analysis of the rpoB gene has been pro-
posed as a method for bacterial identification (15) and has
been used to identify bacterial isolates in a number of taxa,
including Pseudomonas (2), Corynebacterium (8), and the
staphylococci (14). The combination of the multiplex PCR and
rpoB sequencing allowed us to quickly and accurately identify
the predominant Vibrio species that are pathogenic to humans,
unambiguously place unidentified Vibrio isolates into species
within a phylogenetic framework, and identify isolates that
appear to represent as-yet-unnamed Vibrio species.
MATERIALS AND METHODS
A total of 316 bacterial isolates were used in the study: 309 Vibrio isolates,
representing 26 named species, as well as isolates in the genera Photorhabdus
(one), Salmonella (one), Yersinia (one), and Aeromonas (four). We included
Vibrio (Grimontia) hollisae and Vibrio (Photobacterium) damsela among the 12
species that are pathogenic to humans. All isolates were obtained from the
frozen culture collection in the Foodborne and Diarrheal Diseases Branch of the
CDC. Isolates were stored at 70°C in tryptic soy broth with 20% glycerol.
PCR template preparation. Crude lysates were prepared for PCR as follows.
Species pathogenic to humans were grown overnight at 35°C on tryptic soy agar
plates with 5% sheep blood. Marine species were grown on marine agar plates
and incubated at either room temperature or 20°C (V. logei) for 48 h. After
incubation, a single colony was scraped from the plate’s surface and suspended
in 200 l of 1 Tris-EDTA, pH 8.0. The suspension was then heated at 95°C for
10 min and centrifuged for 2 min to pellet cellular debris.
Development of the multiplex assay. We initially used information in GenBank
(http://www.ncbi.nlm.nih.gov/GenBank/) to select target genes for the multiplex
assay. Vibrio species were well represented for two variable genes in the data-
base: hsp60 (11) and sodB (Yoshiyuki Yamada, unpublished data). Sequences for
the two genes were downloaded from GenBank, and each was aligned with
ClustalX (22). We visually searched for sequence regions that potentially could
differentiate individual pathogenic species from other Vibrio spp., and candidate
primer sites were identified for V. vulnificus, V. mimicus, and V. cholerae. In-
traspecific variation within each site was then assessed for V. vulnificus in hsp60
(18 isolates; primers from reference 23) and for V. cholerae and V. mimicus in
TABLE 1. Sequence of primers and final concentration and product size for each of five primer pairs in the multiplex PCR
Target species Primer Sequence (5 to 3) Concn (M) Ampliconsize (bp)
V. cholerae Vc.sodB-F AAG ACC TCA ACT GGC GGT A 0.5 248
Vc.sodB-R GAA GTG TTA GTG ATC GCC AGA GT
V. mimicus Vm.sodB-F CAT TCG GTT CTT TCG CTG AT 0.75 121
Vm.sodB-R2 GAA GTG TTA GTG ATT GCT AGA GAT
V. parahaemolyticus Vp.flaE-79F GCA GCT GAT CAA AAC GTT GAG T 1.0 897
Vp.flaE-934R ATT ATC GAT CGT GCC ACT CAC
V. vulnificus Vv.hsp-326F GTC TTA AAG CGG TTG CTG C 0.25 410
Vv.hsp-697R CGC TTC AAG TGC TGG TAG AAG
All Vibrio spp. V.16S-700F CGG TGA AAT GCG TAG AGA T 0.05 663
V.16S-1325R TTA CTA GCG ATT CCG AGT TC
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sodB (48 V. cholerae isolates and 19 V. mimicus isolates; primers courtesy of
Yoshiyuki Yamada). For the V. parahaemolyticus marker, we downloaded four
Vibrio genome sequences from GenBank (V. parahaemolyticus, NC 004603/NC
0046053; V. cholerae, NC 002505/NC 002506; V. fischeri, NC 006840/NC 006841;
and V. vulnificus, NC 004459/004460) and then extracted and aligned sequences
for the flagellin genes. Primers were designed to match the flaE sequence of V.
parahaemolyticus. A highly conserved, positive internal control for the multiplex
PCR was developed on the basis of an alignment of Vibrio and Enterobacteriaceae
16S rRNA gene sequences.
Optimization was performed for each primer pair individually and then all
primers in combination. Final primer concentrations were adjusted to give ap-
proximately equal signals for each gene fragment. Each reaction contained 2
units of AmpliTaq Gold (Applied Biosystems, Foster City, CA), and final con-
centrations of each deoxynucleoside triphosphate (dNTP) and MgCl2 of 0.2 mM
and 1.5 mM, respectively, and primer concentrations ranged from 0.05 M to 1
M (Table 1). Thus, a typical 20-l reaction mixture contained 1.5 l crude
lysate, 0.2 l of AmpliTaq Gold, 2 l dNTP stock (2 mM each), 2 l 10 buffer,
1.2 l MgCl2 stock (25 mM), 2.9 l double-distilled water, and the various
amounts of each 10 M stock of the primers: Vc primers, 1 l each; Vm primers,
1.5 l each; Vp primers, 2 l each; Vv primers, 0.5 l each; and 16S rRNA
primers, 0.1 l each. The thermal cycling profile was as follows: a 15-min soak at
93°C followed by 35 cycles of 92°C for 40 s, 57°C for 1 min, and 72°C for 1.5 min
and a final soak at 72°C for 7 min. PCR amplicons were electrophoresed in 1.5%
agarose for 1 h at 100 V and then visualized by ethidium bromide staining and
UV illumination. The result for each isolate was determined by comparison to
those for control isolates of V. mimicus, V. cholerae, V. vulnificus, and V. para-
haemolyticus. Any isolate for which the original identification did not match our
multiplex results, or which could not be classified based on the PCR or pheno-
typic characters, was subjected to rpoB sequence determination and phylogenetic
analysis as described below.
rpoB amplification and sequence determination. We developed primers to
amplify and sequence a 984-bp portion of the rpoB gene by first extracting rpoB
sequences from Vibrio genome sequences and aligning them with Enterobacteri-
aceae sequences reported in the work of Mollet et al. (15). We used primers
CM32b (15) and 1110F (5-GTA GAA ATC TAC CGC ATG ATG-3) for
amplification and two additional primers for sequencing (1661F, 5-TTY ATG
GAY CAR AAC AAC CC-3; 1783R, 5-GGA CCT TYA GGN GTT TCG
AT-3). The 50-l PCR mixtures contained 2 units of AmpliTaq Gold, 1.5 l of
crude lysate, and the following reagents at the final concentrations listed in
parentheses: primer (0.5 M each), dNTPs (0.2 mM each), Betaine (1 mM)
(Sigma-Aldrich, St. Louis, MO), and MgCl2 (1.5 mM). The touchdown PCR was
preceded by a 15-min soak at 93°C. The thermal cycle was as follows: 92°C for
FIG. 1. Agarose gels showing results of the multiplex PCR. L, low-molecular-mass ladder. Controls are labeled as follows: A, no-DNA control;
M, V. mimicus; C, V. cholerae; V, V. vulnificus; P, V. parahaemolyticus. Gel A: samples 1 to 3, V. mimicus; samples 4 to 10, V. cholerae serogroup
O1 Ogawa, Inaba, non-O1, O139, O141, O22, and O155, respectively. Gel B: samples 1 to 6, V. vulnificus; samples 7 to 10, V. parahaemolyticus
O4:K68, O3:K6, O3:K6, and O3:K48, respectively. Gel C: sample 1, V. alginolyticus; sample 2, V. cincinnatiensis; sample 3, P. damsela; sample 4,
V. fluvialis; sample 5, V. furnissii; sample 6, V. harveyi; sample 7, V. hollisae; sample 8, V. metschnikovii; sample 9, V. splendidus; sample 10, V.
campbellii. Note that the 16S rRNA control amplicon is usually outcompeted by the species-specific amplicons, but it is clearly visible in some
samples, particularly samples of V. parahaemolyticus (e.g., gel A, V. cholerae sample 7, and gel B, V. parahaemolyticus samples 7, 9, and 10).
TABLE 2. Summary of multiplex results for 316 bacterial isolates,
listed by original species identification
Original
identification
No. of
isolates Multiplex result
V. choleraea 40 V. cholerae amplicon
V. parahaemolyticusb 63 V. parahaemolyticus amplicon
V. vulnificus 60 V. vulnificus amplicon
V. mimicus 27 V. mimicus amplicon
V. alginolyticus 22 16S rRNA amplicon
V. alginolyticus 1 V. parahaemolyticus ampliconc
V. fluvialis 28 16S rRNA amplicon
P. damsela 7 16S rRNA amplicon
V. furnissii 1 16S rRNA amplicon
V. harveyi/trachuri 2 16S rRNA amplicon
G. hollisae 10 16S rRNA amplicon
V. metschnikovii 1 16S rRNA amplicon
V. cincinnatiensis 2 16S rRNA amplicon
V. aestuarianus 1 16S rRNA amplicon
V. anguillarum 5 16S rRNA amplicon
V. campbellii 1 16S rRNA amplicon
V. costicola 1 16S rRNA amplicon
V. halioticoli 4 16S rRNA amplicon
V. logei 1 16S rRNA amplicon
V. natriegens 2 16S rRNA amplicon
V. nereis 1 16S rRNA amplicon
V. nigripulchritudo 1 16S rRNA amplicon
V. ordalii 1 16S rRNA amplicon
V. orientalis 3 16S rRNA amplicon
V. pectenicida 2 16S rRNA amplicon
V. pelagius 4 16S rRNA amplicon
V. splendidus 3 16S rRNA amplicon
Vibrio sp. 12 16S rRNA amplicon
Vibrio sp. 3 V. parahaemolyticus ampliconc
Aeromonas sp. 4 16S rRNA amplicon
Photorhabdus sp. 1 16S rRNA amplicon
Salmonella sp. 1 16S rRNA amplicon
Yersinia sp. 1 16S rRNA amplicon
a Included serogroups O1, O139, and O141.
b Included serotype O3:K6.
c Results confirmed by 16S rRNA and rpoB sequence determination.
TABLE 3. Genetic variation within 870 bp of the rpoB gene in 11
Vibrio speciesa
Species No. ofstrains
No. of
STsb
No. of
polymorphic
sites
dS/100c dN/100d
dN 
dS/100
V. alginolyticus 10 5 6 0.6 0.00 0.60
V. harveyi 4 4 18 3.2 0.16 3.05
V. parahaem-
olyticus
11 6 17 1.8 0.03 1.73
V. vulnificus 7 7 22 3.7 0.00 3.69
V. metschnikovii 2 2 1 0.4 0.00 0.39
V. fluvialis 6 5 12 2.0 0.00 2.00
V. furnissii 3 3 6 1.6 0.00 1.57
V. mimicus 5 5 18 2.9 0.07 2.86
V. cholerae 7 3 6 0.7 0.00 0.67
V. damsela 3 3 4 1.0 0.00 1.04
V. hollisae 5 2 17 2.6 0.07 2.52
a Calculations include the isolates identified by rpoB sequencing.
b ST, sequence type; no. of STs indicates the number of unique sequences.
c dS/100, average number of synonymous substitutions per 100 synonymous
sites.
d dN/100, average number of nonsynonymous substitutions per 100 nonsynony-
mous sites.
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40 s, 60°C to 50°C for 1 min (decreasing 1°C each cycle, then 50°C for 30 cycles),
72°C for 1.5 min, and a final soak at 72°C for 7 min. Agarose gel electrophoresis
and ethidium bromide staining were used to check the quality and quantity of
PCR product, and amplicons were then purified with the QIAquick PCR puri-
fication kit (QIAGEN, Valencia, CA). The product was quantified by compari-
son to a known quantity of the low-molecular-mass ladder (Invitrogen, Carlsbad,
CA) on an ethidium bromide-stained gel. We used the DTCS Quickstart kit
(Beckman Coulter, Fullerton, CA), following manufacturer’s instructions with
the following specifications: we used 1 l of a 20 M primer stock solution, 50
fmol of template, an annealing temperature of 50°C, and Betaine at a final
concentration of 1 mM. Sequence determination was conducted on a Beckman
CEQ 8000 Genetic Analysis system.
Chromatograms were imported into SEQMAN in the package DNAStar (La-
sergene), assembled into contigs, edited, and exported as FASTA files. The rpoB
sequences were aligned with ClustalX, and pairwise genetic distances were cal-
culated using the Kimura two-parameter method in the program MEGA (10).
The rpoB sequences from three published Vibrio genome sequences were also
included in the analysis (7, 9, 12). A neighbor-joining tree was constructed from
the genetic distance matrix, and the bootstrap confidence intervals for each node
were calculated over 1,000 replicate trees.
Nucleotide sequence accession numbers. GenBank accession numbers for
sequences generated in this study are EF 064367 to EF 064446.
RESULTS AND DISCUSSION
Multiplex results. The multiplex assay was tested on a col-
lection of 316 bacterial isolates that included 309 Vibrio iso-
lates. Among these 309 isolates were 190 isolates representing
the four target species, isolates representing an additional 22
named species (see Table 2), and a total of 15 isolates that had
been identified only to genus level. Representative gels are
shown in Fig. 1. All 190 isolates of the four target species
yielded the expected species-specific amplicon (Table 2). For
three of the target species, the 16S rRNA amplicon was usually
outcompeted by the species-specific amplicon, but both ampli-
cons were usually visible for V. parahaemolyticus (Fig. 1). Only
the 16S rRNA fragment was amplified from the isolates rep-
resenting the remaining 22 species, as expected. Of the 15
isolates that were previously identified only to genus level,
three (9564-98, 2410-00, and 2423-02) yielded the V. para-
haemolyticus amplicon. Also, the V. parahaemolyticus ampli-
con was obtained for one isolate that was originally reported
to the CDC as V. alginolyticus (F8891), a result that is not
too surprising given the similar biochemical profiles of the
two species (6). The classification of these four isolates as V.
parahaemolyticus was confirmed using nucleotide sequenc-
ing and evolutionary analysis of a segment of the rpoB gene
as described below. Thus, we found that the multiplex PCR
rapidly and accurately discriminated four Vibrio species that
account for the majority of Vibrio infections in the United
States each year (4).
FIG. 2. Neighbor-joining tree constructed from Kimura two-
parameter distances calculated from 870 bp of rpoB sequence. The
numbers at each node indicate the percentage of bootstrap replications
in which a particular node appears (shown for nodes where value was
50%). Isolates that were identified by rpoB sequence analysis are
shown highlighted in gray and are designated by the original identifi-
cation. The rpoB sequences for Escherichia coli K-12 and Shigella
flexneri 2a were extracted from complete genome sequences down-
loaded from GenBank (accession numbers NC 000913 and NC 004337,
respectively). GenBank accession numbers for sequences generated in
this study are EF 064367 to EF 064446.
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rpoB sequencing results. We obtained 870 bp of sequence
from a total of 60 Vibrio isolates that had been classified by
biochemical methods, 15 isolates that could not be classified on
the basis of phenotype, and four isolates of other enteric bac-
teria that were included to root the phylogenetic tree. The
rpoB gene was polymorphic within all 11 of the pathogenic
Vibrio species for which we sequenced more than one isolate
(Table 3). The synonymous substitution rate (dS) was greater
than the nonsynonymous substitution rate (dN), as was ex-
pected for a conserved housekeeping gene (Table 3).
All Vibrio species included in the analysis were distinguish-
able from isolates of other species on the basis of their rpoB
sequence (Fig. 2). The level of bootstrap support for each of
the pathogenic species clusters was very high, ranging from
93% for V. fluvialis isolates to 100% for most of the other
Vibrio species (Fig. 2). The closest species pair was V. harveyi
and V. campbellii, which differed at two nucleotide sites
(0.23%). Genetic distances for other closely related species
pairs were 2.1% (V. fluvialis and V. furnissii), 3.2% (V. algin-
olyticus and V. parahaemolyticus), and 4.2% (V. cholerae and V.
mimicus) (Table 4). The species clusters based on the rpoB
phylogeny were consistent with the results based on sequenc-
ing of other loci (19).
We sequenced a total of 15 isolates that were not classified
by phenotypic methods because they differed in one or more
biochemical characteristics from other Vibrio isolates. Infor-
mation on the isolates is shown in Table 5. The sequences from
10 of the isolates fell within the core Vibrio group: four clus-
tered with V. alginolyticus, three with V. parahaemolyticus, and
three with the V. harveyi-related group. The sequences from
the remaining five isolates were scattered in the tree, with one
isolate clustering with V. anguillarum, one with V. fluvialis, and
one with V. hollisae. Two of the Vibrio sequences did not
cluster with any of the other groups in the tree. An isolate
(F8891) that had been reported to the CDC as V. alginolyticus
did not cluster with other sequences for that species but in-
stead clustered with V. parahaemolyticus, which was consistent
with the results from the multiplex PCR assay.
The cluster of isolates including V. harveyi raised questions
about classification of these closely related isolates. Thompson
TABLE 4. Average nucleotide distance between each pair of Vibrio species calculated for the rpoB genea
Species
Nucleotide distance
1 2 3 4 5 6 7 8 9 10 11 12
1. V. alginolyticus 35.8 27.6 78.1 140.5 145.8 106.3 109.0 111.1 117.4 145.9 170.6
2. V. harveyi 4.2 44.6 103.2 149.0 150.5 108.5 110.8 108.3 116.0 151.0 180.3
3. V. parahaemolyticus 3.2 5.3 81.0 141.0 146.9 111.2 111.5 111.0 117.5 149.2 175.5
4. V. vulnificus 9.6 13.0 10.0 126.5 130.6 108.5 116.2 116.3 117.4 147.3 164.2
5. V. metschnikovii 18.4 19.7 18.5 16.4 116.5 138.3 142.8 132.7 124.2 173.5 198.9
6. V. cincinnatiensis 19.2 19.9 19.4 17.0 14.9 135.3 131.7 121.4 120.4 188.0 197.2
7. V. fluvialis 13.4 13.7 14.1 13.8 18.2 17.7 18.3 81.5 83.4 163.3 173.2
8. V. furnissii 13.8 14.1 14.2 14.9 18.9 17.1 2.1 83.4 83.7 166.7 176.3
9. V. mimicus 14.1 13.7 14.1 14.9 17.4 15.7 10.0 10.3 35.1 170.2 177.1
10. V. cholerae 15.0 14.8 15.0 15.1 16.1 15.6 10.3 10.4 4.2 170.6 173.5
11. V. damsela 19.0 19.8 19.5 19.3 23.4 25.7 21.7 22.2 22.8 22.8 139.0
12. V. hollisae 23.0 24.5 23.7 22.0 27.8 27.3 23.3 23.8 24.0 23.4 18.2
a Upper right triangle, number of nucleotide differences; lower left triangle, genetic distance based on Kimura two-parameter model.
TABLE 5. Characteristics of 15 isolates that were identified by rpoB sequence determination and phylogenetic analysis
Isolate Source Yra Locality Closest matchb Molecular identification(rpoB) Atypical phenotype
c
9866-84 Environment 1984 Aegean Sea V. harveyi group 2 V. harveyi related NA
9564-98 Unknown 1998 Texas V. harveyi V. parahaemolyticus Ind Orn Lip
2403-00 Blood 2000 Texas V. fluvialis V. fluvialis Oxi
2410-00 Stool 2000 North Carolina V. alginolyticus V. parahaemolyticus Cit Suc Sal ONPG
2419-00 Stool 2000 Colorado No match No close relationship NA
2401-01 Gall bladder 2001 Massachusetts V. harveyi V. alginolyticus VP Mot
2421-01 Oyster (outbreak) 2001 Nevada No match V. anguillarum NA
2423-01 Blood 2001 Virginia V. vulnificus No close relationship NA
2439-01 Stool 2001 Maryland V. alginolyticus V. alginolyticus Cit Sal
2422-02 Wound 2002 Hawaii V. alginolyticus V. harveyi (trachuri) MR Lip Gal
2423-02 Stool 2002 Louisiana V. vulnificus V. parahaemolyticus Cit Suc Sal Cel
2419-03 Nasal sinus 2003 Indiana V. alginolyticus V. alginolyticus VP Cit
2420-03 Nasal sinus 2003 Indiana V. alginolyticus V. alginolyticus VP Cit Acet
2429-03 Stool 2003 Louisiana V. vulnificus V. hollisae MR Gly
2415-05 Blood 2005 Hawaii V. harveyi V. harveyi (trachuri) Orn Tyr Gal
a Year in which the isolate was received at the Centers for Disease Control and Prevention.
b The species identification with the highest probability score based on phenotype matching.
c An atypical phenotype is one that is seen in 14% or fewer of the isolates of a given species (Table 3) (6). Results are not given for isolates that did not fall within
any of the 12 Vibrio species that are pathogenic to humans. Abbreviations for phenotypic tests: Acet, sodium acetate; Cel, cellobiose; Cit, Simmons citrate; Gal,
galactose; Gly, glycerol; Ind, indole; Lip, corn oil lipase; Mot, motility; MR, methyl red; ONPG, o-nitrophenyl--D-galactopyranoside; Orn, ornithine decarboxylase;
Oxi, oxidase; Sal, salicin; Suc, sucrose; VP, Voges-Proskauer. NA, not applicable.
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et al. (20) suggested that V. trachuri is synonymous with V.
harveyi. The V. campbellii and V. harveyi isolates included here
had rpoB sequences that differed by only two nucleotides.
These two isolates differed from the cluster of “V. trachuri” and
two unknowns by 15 to 19 nucleotides (1.8 to 2.2%), a level of
divergence that is similar to that observed between V. fluvialis
and V. furnissii and also between two distinct clusters of V.
vulnificus (Fig. 2; Table 4). In this case, divergence alone can-
not dictate a species boundary; however, based on the phylog-
eny shown here, principles of phylogenetic classification would
require either that V. harveyi also include V. campbellii to avoid
paraphyly in the species or that V. trachuri be a separate spe-
cies along with V. campbellii and V. harveyi. Further study is
needed to resolve the relationships between the isolates in the
V. harveyi cluster.
The V. harveyi cluster also included isolate 9866-84, an iso-
late that was included because it could not be classified by
phenotypic methods. The average genetic distance between
9866-84 and other isolates in the cluster was 4.2%, a value that
was consistent with distances between closely related species
(V. cholerae and V. mimicus, 4.2%; V. parahaemolyticus and V.
alginolyticus, 3.2%). We suggest that this isolate is a species
closely related to, but separate from, V. harveyi.
The rpoB sequences of two other clinical isolates (2419-00,
from stool, and 2423-01, from blood) were divergent from all
other Vibrio sequences included here (d  13%) and did not
cluster with any other sequences in the phylogenetic tree. Be-
cause our rpoB database does not yet include all described
Vibrio species, we needed additional information to determine
if these two isolates represented previously named Vibrio spe-
cies. Thus, we sequenced a portion of the 16S rRNA gene and
conducted BLAST searches of GenBank to assess the se-
quences’ relatedness to other Vibrio isolates (data not shown).
The two isolates did not closely match any named species on
the basis of the 16S rRNA gene sequence: the closest named
species to isolate 2419-00 was V. harveyi (980/986-bp match,
99% similarity) and to isolate 2423-01 was V. cholerae (1,515/
1,545-bp match, 98% similarity). On the basis of the rpoB and
16S rRNA gene sequence analysis, we conclude that these two
isolates likely represent unnamed Vibrio species.
The two-step approach that we have presented here allows
rapid and accurate discrimination of the Vibrio species that are
implicated in human infections. The advantages of our multi-
plex are that conserved housekeeping genes are used as a
source of markers so that the targeted gene is present in all
isolates of a species and multiple species can be discriminated
with a single PCR assay. The assay is designed as a rapid
classification tool for clinical laboratories, but the markers
themselves could be incorporated into other PCR and DNA
microarray assays that use virulence genes as markers for
pathogenic species (e.g., reference 17). We note that this assay
used alone would not assess the pathogenic potential of bac-
teria in environmental samples, where virulence determination
is important in assessing the risk of human illness. We are
currently developing molecular probes for the remaining Vibrio
human pathogens and adapting the assay to a Luminex plat-
form (Luminex Corporation, Austin, TX) to provide a single
assay that can rapidly detect and identify the 12 species that are
pathogenic to humans.
The rpoB gene also provides a useful identification tool; its
advantages over the 16S rRNA gene are that it exists as a
single-copy gene and it has sufficient phylogenetic signal to
discriminate among all of the Vibrio species that we have se-
quenced to date. Thus, our rpoB reference database that we
are assembling will augment the identification of Vibrio species
by PCR assays and by sequence-based approaches under way
in other laboratories (19).
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